Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019

SELL
$72.81 - $156.91 $65,529 - $141,219
-900 Closed
0 $0
Q1 2019

Apr 12, 2019

BUY
$106.67 - $151.68 $96,003 - $136,512
900 New
900 $107,000
Q1 2018

Apr 20, 2018

SELL
$54.02 - $82.27 $54,020 - $82,270
-1,000 Closed
0 $0
Q4 2017

Jan 22, 2018

BUY
$47.64 - $56.75 $47,640 - $56,750
1,000
1,000 $55,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track First Manhattan CO Portfolio

Follow First Manhattan CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.